Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Biomed-lublin Wytw.sur.i Szcz. buy krebskrebs

Biomed-lublin Wytw.sur.i Szcz.
Start price
€1.55
26.07.22 / 50%
Target price
€1.50
26.07.23
Performance (%)
-30.83%
End price
€1.07
27.07.23
Summary
This prediction ended on 27.07.23 with a price of €1.07. The BUY prediction by krebskrebs for Biomed-lublin Wytw.sur.i Szcz. performed very badly with a performance of -30.83%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Biomed-lublin Wytw.sur.i Szcz. - - - -
iShares Core DAX® 4.642% 7.489% 6.987% 53.734%
iShares Nasdaq 100 4.471% 16.803% 40.281% 104.329%
iShares Nikkei 225® 7.670% 16.856% 47.874% 73.793%
iShares S&P 500 2.472% 9.903% 28.430% 72.579%

Comments by krebskrebs for this prediction

In the thread Biomed-lublin Wytw.sur.i Szcz. diskutieren
Prediction Buy
Perf. (%) -30.83%
Target price 1.500
Change
Ends at

Buy mit Kursziel 1,5

krebskrebs 
0
Report Share
26.07.22
In the thread Trading Biomed-lublin Wytw.sur.i Szcz.
Prediction Buy
Perf. (%) -30.83%
Target price 1.500
Change
Ends at 26.07.23

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

krebskrebs 
0
Report Share
27.07.23